Valuentum Exclusive Analysis for the Discerning Investor

Symbol Keyword

Member Login Email Password Join Now Forgotten Password Newsletters/Portfolios View Current and Archived Dividend Growth Newsletters View Current and Archived Best Ideas Newsletters Valuentum's Dividend Growth Newsletter Portfolio Valuentum's Best Ideas Newsletter Portfolio Order the Exclusive Publication! View Current and Archived Exclusive Editions Order the High Yield Dividend Newsletter! Dividend Cushion Efficacy Calculation Dividend-Adjusted Leverage White Paper Stock Screens How to Filter Data in Microsoft Excel Like a Pro Download Weekly Stock Screener (xls) -- login required The Quarterly DataScreener Products & Tools Financial Advisor (GOLD LEVEL) Publications DCF Valuation Model Template Order Value Trap Order Value Trap, second edition Value Trap Order PDF Copy Order Paperback Copy Presentation BookLife Review BlueInk Review Foreword Review Readers' Favorite Review Axiom Bronze Praise The Buying Index, VBI Value and Momentum Within Stocks, Too (2017) The Case for the Valuentum Style of Investing (2012) Investing's Odd Couple: Value and Momentum (2013) Stock-Selection Methodology, the Valuentum Buying Index (2011) Why Valuentum Buying Index Ratings Matter (2014) Dividend Changes Dividend Increases/Decreases for the Week of November 8 Dividend Increases/Decreases for the Week of November 1 Dividend Increases/Decreases for the Week of October 25 Dividend Increases/Decreases for the Week of October 18 Dividend Increases/Decreases for the Week of October 11 Dividend Increases/Decreases for the Week of October 4

Results 11 - 20 of 132 for mye. (0.22 seconds) Guide to Second Quarter Earnings; Big Pharma Experiencing Earnings Momentum Abbott, Bristol-Myers, Celgene, Eli... Around the Horn in Biotech/Pharma: 3Q Earnings Review Abbott, Biogen, Bristol-Myers, Eli... “Bought” Low and “Sold” Low with Meta Image: Shares of Meta Platforms have been on a wild ride... Public Storage Raises Core FFO Guidance for 2023 Image Source: Public Storage. Among the REIT... Oracle’s “Business Is Good and Getting Better” Image Source: Peter Kaminski. On December 11, Oracle... Despite Lackluster Results, Johnson & Johnson Remains a Solid Dividend-Growth Holding Johnson & Johnson did little to impress investors... Johnson and Johnson’s Deal for Synthes Closes; Healthcare Spending Will Grow We take a look at some recent developments in the... 2018 Healthcare and Biotech Outlook Image Source: Global Panorama. 2017 will undoubtedly... Dividend Increases for the Week Ending March 6 Let's take a look at dividend increases for the week... AstraZeneca Is Not Immune to Patent Cliff AstraZeneca faced revenue and earnings pressure from the... prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | next